Cartherics Pty Ltd

Today, Cartherics hosted a Frocktober lunch to support ovarian cancer awareness and research. Our team came together, in our most fabulous frocks and colourful shirts, to raise both spirits and funds for this important cause. We were honoured to hear from OCRF ambassador Kate Wyatt, who shared inspiring insights about her journey with ovarian cancer. Her story highlights the importance of raising awareness and supporting those affected by this disease. It’s a reminder of the impact we can make when we unite for a common goal. Thank you to everyone who participated, donated, and helped make this event a success! Let’s continue to raise awareness and advocate for change. Together, we can make a difference! Read more here: https://lnkd.in/gYKi6uiN #Frocktober2024 #OvarianCancerAwareness

We’re delighted to announce that Prof. Alan Trounson, CEO of Cartherics, will be joining a panel discussion on iPSC-derived cell therapies at AusBiotech’s conference at 3:35 pm on Thursday, 31st October 2024. The session, titled "Thinking Big: How iPSC-Derived Therapies Can Get Out of the Niche," will provide invaluable insights into the potential and challenges of these groundbreaking therapies. The discussion will delve into scientific, regulatory, and manufacturing aspects of iPSC therapies, as well as emerging technologies like modified and armored cell therapies. See the program here: https://lnkd.in/gWph8vAv #iPSC #PanelDiscussion

Spotlight on Prof. Bryan Williams - Board Member at Cartherics   We’re pleased to highlight Prof. Bryan Williams, a key board member at Cartherics, whose vast experience in cancer research is helping drive the company’s mission to revolutionise cancer treatments. With decades of expertise in immunotherapy and cellular medicine, Prof. Williams brings invaluable insight into the development of novel therapies, making him an essential leader in our pursuit of groundbreaking treatments for hard-to-treat cancers and other difficult diseases.   We sincerely thank Bryan for his invaluable contributions and dedication to Cartherics, as his expertise continues to play a crucial role in advancing our mission to transform cancer care. #BoardMember #ScientificLeadership

This October, we're blending science, style, and social impact in support of Frocktober - a campaign that raises awareness and funds for ovarian cancer research. In the lead up to our Frocktober event in a few weeks, we’re taking the iconic lab coat and transforming it into a fashion statement and a powerful symbol of advocacy for ovarian cancer awareness. With the current five-year survival rate for ovarian cancer at just 49%, it remains the most lethal gynaecological cancer. Funding vital medical research into early detection, prevention, and treatment is the only way to improve outcomes for women, girls, and their families everywhere. Let’s make science a little more vibrant and impactful this Frocktober, and together, drive change for ovarian cancer awareness and research! #Frocktober #OvarianCancerAwareness

Cartherics is #hiring! We are looking for a talented Research Scientist to join our R&D team. Reporting to the Group Leader, this role will focus primarily on hands-on in vivo experimental work, as well as in vitro experiments to support various projects within our R&D pipeline. This is an exciting opportunity to join a dynamic biotech company developing life-changing cancer therapies. Ready to take the next step in your career? Check out the full job description and apply here: https://lnkd.in/gsjnCZYy #JobOpportunity #ResearchScientist

A heartfelt thank you to Robyn Riley for your insightful article in today’s Herald Sun. Your article highlights the innovative research that could change lives and offers hope to so many. Thanks for the support!

Exciting news from Cartherics!  We are pleased to announce that we have successfully raised well over our target of AU$15M in an oversubscribed financing round! This incredible support not only reflects the confidence investors have in our vision but also propels us forward in our mission to revolutionise cancer treatment. This funding will support the initiation of the clinical trial for CTH-401, our lead cell therapy product targeting ovarian cancer. Additionally, we are eager to broaden our pipeline to explore other disease indications, further enhancing our commitment to advancing innovative therapies. Thank you to all our investors, partners, and supporters who believe in our mission. Read more here: https://lnkd.in/gru4Fzer  #CellTherapy #Investment  

Cartherics is #hiring! We’re looking for a talented Cell Production Operator/Assistant to support manufacture of the Company’s CAR-NK cells for clinical trials as part of the Manufacturing Development team.  As a Cell Production Operator/Assistant, your day will be filled with diverse and critical tasks. Your role involves assisting the Manufacturing Development team and ensuring adherence to all standard operating procedures and Good Manufacturing Practices. If you’re passionate about playing a vital part in advancing innovative therapies, check out the full job description and apply here: https://lnkd.in/gNyZSpxK #JobOpportunity #CellProduction #CARNKCells

Cartherics is #hiring! We’re looking for a talented Research Scientist/Production Operator to join our team! This hybrid role combines responsibilities as a Production Operator in a GMP contract manufacturing facility and as a Research Scientist in a PC2 laboratory. The successful candidate will initially focus on producing clinical trial material before advancing to manufacturing process improvement, gaining valuable experience in advanced technologies and research methods. Ready to take the next step in your career? Check out the full job description and apply here: https://lnkd.in/gkfnJTms #JobOpportunity #ResearchScientist #ProductionOperator

Australia punches well above its weight in medical breakthroughs, and my guest this week has pioneered THREE of them! Alan Trounson is a true pioneer in medicine. From his early career, where he led the arrival of Australia's first IVF baby, to his groundbreaking research in stem cells - Alan has never been afraid to challenge the status quo. His approach to medicine has seen him work directly with the likes of Arnold Schwarzenegger, and has led him to his current current mission - harnessing the immune system to fight cancer via his company Cartherics Pty Ltd. Impressively, after all he's achieved - Alan believes his greatest contribution to medicine is still yet to come! Alan, your contributions to science have been truly remarkable, thanks again for joining us. Link to the episode in the comments. #GrinAndBareIt #AlanTrounson #Cancer #IVF #StemCellResearch #CancerResearch #Immunotherapy #MedicalBreakthroughs #WomensHealth #MedicalPioneers #Oncology #HealthcareInnovation #AIInHealthcare #EthicalDilemmas